Johan M. Spoor

Insider Reports History

Location
2401 Elliott Avenue, Suite 320, Seattle, WA
Signature
/s/ Johan (Thijs) Spoor by Chris Nenno, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Johan M. Spoor:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Perspective Therapeutics, Inc. Chief Executive Officer, Director Common Stock 59.4K $133K $2.24 Mar 28, 2025 Direct
Perspective Therapeutics, Inc. Chief Executive Officer, Director Common Stock 12.6K $27K $2.14 Mar 28, 2025 By IRA of Spouse
Perspective Therapeutics, Inc. Chief Executive Officer, Director Common Stock 5.4K $11.6K $2.14 Mar 28, 2025 By IRA of Reporting Person
Perspective Therapeutics, Inc. Chief Executive Officer, Director Common Stock 4.65K $10.3K $2.21 Mar 28, 2025 By Child #1
Perspective Therapeutics, Inc. Chief Executive Officer, Director Common Stock 4.65K $9.97K $2.14 Mar 28, 2025 By Child #2
Perspective Therapeutics, Inc. Chief Executive Officer, Director Common Stock 1K $2.14K $2.14 Mar 28, 2025 By Spouse
Perspective Therapeutics, Inc. Chief Executive Officer, Director Stock option (right to buy) 650K Mar 3, 2025 Direct

Insider Reports Filed by Johan M. Spoor

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CATX Perspective Therapeutics, Inc. Mar 28, 2025 2 $59.7K 4 Apr 1, 2025 Chief Executive Officer, Director
CATX Perspective Therapeutics, Inc. Mar 3, 2025 1 $0 4 Mar 5, 2025 Chief Executive Officer, Director
CATX Perspective Therapeutics, Inc. Dec 4, 2024 1 $30.1K 4 Dec 4, 2024 CEO, Director
CATX Perspective Therapeutics, Inc. Nov 25, 2024 0 $0 4/A Dec 4, 2024 CEO, Director
CATX Perspective Therapeutics, Inc. Jun 20, 2024 1 $0 4 Jun 24, 2024 CEO, Director
CATX Perspective Therapeutics, Inc. Jun 13, 2024 1 $117K 4 Jun 13, 2024 CEO, Director
CATX Perspective Therapeutics, Inc. Dec 12, 2023 1 $0 4 Dec 14, 2023 CEO, Director
CATX Isoray, Inc. Feb 3, 2023 0 $0 3 Feb 13, 2023 CEO, Director